• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸主动脉瘤患者的原纤蛋白-1(FBN1)突变

Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms.

作者信息

Milewicz D M, Michael K, Fisher N, Coselli J S, Markello T, Biddinger A

机构信息

Department of Internal Medicine, University of Texas-Houston Medical School, USA.

出版信息

Circulation. 1996 Dec 1;94(11):2708-11. doi: 10.1161/01.cir.94.11.2708.

DOI:10.1161/01.cir.94.11.2708
PMID:8941093
Abstract

BACKGROUND

Mutations in the FBN1 gene are the cause of the Marfan syndrome, an autosomal dominant disorder with skeletal, ocular, and cardiovascular complications. Aneurysms or dissections of the ascending thoracic aorta are the major cardiovascular complications of the disorder. We tested the hypothesis that FBN1 mutations cause thoracic aortic aneurysms or dissections in patients who do not have the Marfan syndrome.

METHODS AND RESULTS

The FBN1 gene was screened for mutations by use of genomic DNA from two patients with thoracic aortic aneurysms who did not have the Marfan syndrome. Individual FBN1 exons were amplified with intron-based exon-specific primers; the DNA fragments were screened for mutations using single-stranded conformational polymorphism analysis; and aberrantly migrating bands were sequenced directly. We identified a missense mutation in one patient, D1155N in exon 27. Dermal fibroblasts from the affected individual were used to study the effect of the missense mutation D1155N on fibrillin-1 cellular processing. The mutation decreased the amount of fibrillin-1 deposited into the pericellular matrix. A second putative FBN1 mutation was identified in the second patient, P1837S in exon 44. Although this alteration was not observed in 234 chromosomes from unrelated individuals, the alteration may represent a rare polymorphism.

CONCLUSIONS

Results of these studies support the hypothesis that FBN1 mutations cause thoracic aortic aneurysms in patients who do not have the Marfan syndrome. This information is important for understanding the pathogenesis of aortic aneurysms and identification of individuals at risk for developing thoracic aortic aneurysms or dissections.

摘要

背景

FBN1基因突变是马方综合征的病因,这是一种常染色体显性疾病,伴有骨骼、眼部和心血管并发症。升主动脉瘤或夹层是该疾病的主要心血管并发症。我们检验了一个假设,即FBN1基因突变会导致非马方综合征患者发生胸主动脉瘤或夹层。

方法与结果

利用两名非马方综合征胸主动脉瘤患者的基因组DNA对FBN1基因进行突变筛查。使用基于内含子的外显子特异性引物扩增各个FBN1外显子;利用单链构象多态性分析筛选DNA片段中的突变;对异常迁移条带直接进行测序。我们在一名患者中鉴定出一个错义突变,位于第27外显子的D1155N。利用来自该患病个体的皮肤成纤维细胞研究错义突变D1155N对原纤维蛋白-1细胞加工的影响。该突变减少了沉积到细胞周围基质中的原纤维蛋白-1的量。在第二名患者中鉴定出第二个假定的FBN1突变,位于第44外显子的P1837S。尽管在来自无关个体的234条染色体中未观察到这种改变,但这种改变可能代表一种罕见的多态性。

结论

这些研究结果支持了FBN1基因突变会导致非马方综合征患者发生胸主动脉瘤这一假设。这一信息对于理解主动脉瘤的发病机制以及识别有发生胸主动脉瘤或夹层风险的个体具有重要意义。

相似文献

1
Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms.胸主动脉瘤患者的原纤蛋白-1(FBN1)突变
Circulation. 1996 Dec 1;94(11):2708-11. doi: 10.1161/01.cir.94.11.2708.
2
The non-syndromic familial thoracic aortic aneurysms and dissections maps to 15q21 locus.非综合征型家族性胸主动脉瘤和夹层定位于 15q21 位点。
BMC Med Genet. 2010 Oct 11;11:143. doi: 10.1186/1471-2350-11-143.
3
Exon 47 skipping of fibrillin-1 leads preferentially to cardiovascular defects in patients with thoracic aortic aneurysms and dissections.纤维连接蛋白 1 外显子 47 跳跃优先导致胸主动脉瘤和夹层患者心血管缺陷。
J Mol Med (Berl). 2013 Jan;91(1):37-47. doi: 10.1007/s00109-012-0931-y. Epub 2012 Jul 8.
4
Missense mutations in FBN1 exons 41 and 42 cause Weill-Marchesani syndrome with thoracic aortic disease and Marfan syndrome.FBN1 外显子 41 和 42 的错义突变导致伴有胸主动脉疾病的马凡综合征和 Weill-Marchesani 综合征。
Am J Med Genet A. 2013 Sep;161A(9):2305-10. doi: 10.1002/ajmg.a.36044. Epub 2013 Jul 29.
5
Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1.全基因组关联研究鉴定出 15q21.1 上跨越 FBN1 的胸主动脉瘤和主动脉夹层易感性位点。
Nat Genet. 2011 Sep 11;43(10):996-1000. doi: 10.1038/ng.934.
6
Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene.与FBN1基因第23-32外显子突变相关的马凡氏综合征表型的描述。
Am J Med Genet. 1996 Mar 29;62(3):233-42. doi: 10.1002/(SICI)1096-8628(19960329)62:3<233::AID-AJMG7>3.0.CO;2-U.
7
FBN1 polymorphisms in patients with the dilatative pathology of the ascending thoracic aorta.升主动脉扩张性病变患者的FBN1基因多态性
Eur J Cardiothorac Surg. 2015 Apr;47(4):e124-30. doi: 10.1093/ejcts/ezu520. Epub 2015 Jan 12.
8
FBN1 mutations in patients with descending thoracic aortic dissections.FBN1 突变与降主动脉夹层患者。
Am J Med Genet A. 2010 Feb;152A(2):413-6. doi: 10.1002/ajmg.a.32856.
9
Three Novel Mutations in FBN1 and TGFBR2 in Patients with the Syndromic Form of Thoracic Aortic Aneurysms and Dissections.患有综合征型胸主动脉瘤和夹层患者的FBN1和TGFBR2中的三种新突变。
Int Heart J. 2018 Sep 26;59(5):1059-1068. doi: 10.1536/ihj.18-046. Epub 2018 Aug 11.
10
The spectrum of FBN1, TGFβR1, TGFβR2 and ACTA2 variants in 594 individuals with suspected Marfan Syndrome, Loeys-Dietz Syndrome or Thoracic Aortic Aneurysms and Dissections (TAAD).594名疑似患有马凡综合征、洛伊氏综合征或胸主动脉瘤及夹层(TAAD)的个体中FBN1、TGFβR1、TGFβR2和ACTA2基因变异情况。
Mol Genet Metab. 2014 Jun;112(2):171-6. doi: 10.1016/j.ymgme.2014.03.011. Epub 2014 Apr 2.

引用本文的文献

1
Current understanding of the genetics of thoracic aortic disease.目前对胸主动脉疾病遗传学的认识。
Vessel Plus. 2024;8. doi: 10.20517/2574-1209.2023.55. Epub 2024 Jan 21.
2
Cellular stiffness sensing through talin 1 in tissue mechanical homeostasis.通过 talin 1 感知细胞硬度在组织力学动态平衡中的作用。
Sci Adv. 2024 Aug 23;10(34):eadi6286. doi: 10.1126/sciadv.adi6286. Epub 2024 Aug 21.
3
Heritable thoracic aortic disease: a literature review on genetic aortopathies and current surgical management.遗传性胸主动脉疾病:关于遗传性主动脉病变及当前外科治疗的文献综述
Gen Thorac Cardiovasc Surg. 2024 May;72(5):293-304. doi: 10.1007/s11748-024-02017-x. Epub 2024 Mar 14.
4
Role of non-coding variants in cardiovascular disease.非编码变异在心血管疾病中的作用。
J Cell Mol Med. 2023 Jun;27(12):1621-1636. doi: 10.1111/jcmm.17762. Epub 2023 May 15.
5
Circulating fibrillin fragment concentrations in patients with and without aortic pathology.患有和未患主动脉病变患者的循环血中纤连蛋白片段浓度
JVS Vasc Sci. 2022 Oct 13;3:389-402. doi: 10.1016/j.jvssci.2022.09.001. eCollection 2022.
6
Loeys-Dietz Syndrome.Loeys-Dietz 综合征。
Adv Exp Med Biol. 2021;1348:251-264. doi: 10.1007/978-3-030-80614-9_11.
7
Gene Therapy for Cardiovascular Disease: Basic Research and Clinical Prospects.心血管疾病的基因治疗:基础研究与临床前景
Front Cardiovasc Med. 2021 Nov 5;8:760140. doi: 10.3389/fcvm.2021.760140. eCollection 2021.
8
Marfan syndrome.马凡综合征。
Nat Rev Dis Primers. 2021 Sep 2;7(1):64. doi: 10.1038/s41572-021-00298-7.
9
Identification of novel genetic susceptibility loci for thoracic and abdominal aortic aneurysms via genome-wide association study using the UK Biobank Cohort.通过使用英国生物库队列进行全基因组关联研究,鉴定胸主动脉瘤和腹主动脉瘤的新遗传易感性基因座。
PLoS One. 2021 Sep 1;16(9):e0247287. doi: 10.1371/journal.pone.0247287. eCollection 2021.
10
Patient-Specific 3-Dimensional Model of Smooth Muscle Cell and Extracellular Matrix Dysfunction for the Study of Aortic Aneurysms.用于研究主动脉瘤的平滑肌细胞和细胞外基质功能障碍的患者特异性三维模型。
J Endovasc Ther. 2021 Aug;28(4):604-613. doi: 10.1177/15266028211009272. Epub 2021 Apr 26.